Xencor, Inc. (XNCR) stock analysis

XNCR · Xencor, Inc.

Latest recorded price: USD 35.40

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth -8.6%, free cash flow margin -110.1%, ROIC -20.9%. The model flags 2 risk signals for this company (1 high severity).

Similar companies in Healthcare